+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Colon Cancer Drugs Market Research Reports

From
From
Colorectal Cancer KOL Interview - UK - Product Thumbnail Image

Colorectal Cancer KOL Interview - UK

  • Newsletter
  • May 2024
  • 14 Pages
  • United Kingdom
Colorectal Cancer KOL Interview - US, Northeast - Product Thumbnail Image

Colorectal Cancer KOL Interview - US, Northeast

  • Newsletter
  • May 2024
  • 14 Pages
  • United States
Cyramza (ramucirumab; Eli Lilly) Drug Overview 2019 - Product Thumbnail Image

Cyramza (ramucirumab; Eli Lilly) Drug Overview 2019

  • Drug Pipelines
  • September 2019
  • 65 Pages
  • Global
Stivarga (regorafenib; Bayer/Amgen) Drug Overview 2019 - Product Thumbnail Image

Stivarga (regorafenib; Bayer/Amgen) Drug Overview 2019

  • Drug Pipelines
  • September 2019
  • 30 Pages
  • Global
Avastin (bevacizumab; Genentech/Roche/Chugai) Drug Overview 2019 - Product Thumbnail Image

Avastin (bevacizumab; Genentech/Roche/Chugai) Drug Overview 2019

  • Drug Pipelines
  • March 2019
  • 111 Pages
  • Global
Colorectal Cancer Forecast and Market Analysis to 2036 - Product Thumbnail Image

Colorectal Cancer Forecast and Market Analysis to 2036

  • Report
  • September 2018
  • 630 Pages
  • Global
From
Global Colorectal Cancer Therapeutics Market 2022-2026 - Product Thumbnail Image

Global Colorectal Cancer Therapeutics Market 2022-2026

  • Report
  • March 2022
  • 120 Pages
  • Global
From
From
From
From
From
From
From
From
Colorectal Cancer: Epidemiology Forecast to 2028 - Product Thumbnail Image

Colorectal Cancer: Epidemiology Forecast to 2028

  • Report
  • November 2019
  • 47 Pages
  • Global
From
Anal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Anal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 589 Pages
  • Global
From
Colorectal Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Colorectal Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 3889 Pages
  • Global
From
Colon Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Colon Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1184 Pages
  • Global
From
Loading Indicator

The Colon Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat colon cancer. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy drugs are used to kill cancer cells and stop them from growing. Targeted therapy drugs are designed to target specific cancer cells and block their growth. Immunotherapy drugs are used to boost the body’s natural immune system to fight cancer cells. Some of the major companies in the Colon Cancer Drugs market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Eli Lilly. These companies are involved in the research, development, and marketing of drugs used to treat colon cancer. Show Less Read more